Said he thinks the FDA used the thee covid study cardiac

New Post Public Reply Private Reply Replies (1) Message Board
Figgs
995
Quote:
Said he thinks the FDA used the thee covid study cardiac cases as cover to implement the hold when the real problem was the SEC investigation.


This whole FDA Hold wreaks of classism and racism; I mean just because you don't like somebody, or think they are a clown, it does not justify holding a drug for bogus reasons. As soon as the cardiac cases cleared the DSMC as not being caused by Leronlimab, the Covid hold should have been gone!

As far as the SEC is concerned, first of all, everyone is presumed innocent until proven guilty, and second, what the hell does that have to do with the safety of Leronlimab?

So drug approval it seems is based more on who you like than how well the drug does.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Insights into LATAM SSP Market Share Analysis of 2025

Updated Category News Views 367

Overview of LATAM SSP Market Share Rankings London — Pixalate, a global frontrunner in ad fraud analytics and privacy compliance, has published its Q1 2025 Supply-Side Platform (SSP) market share reports for Latin America (LATAM). This comprehensive analysis covers significant landscapes such as Connected TV (CTV), mobile applications, and the web, spotlighting...

Continue Reading
Singtel's RE:AI Awarded for Pioneering GPU-as-a-Service Innovation

Updated Category News Views 361

Singtel's Innovative RE:AI Project Takes Center Stage By seamlessly integrating compute, connectivity, and applications orchestration, Singtel's RE:AI is transforming the AI infrastructure landscape and setting fresh benchmarks in GPU-as-a-Service delivery. This project, spearheaded by its digital infrastructure sector known as Digital InfraCo, signifies an important...

Continue Reading
Shareholder Alert: Investigations Affecting Avantor and Others

Updated Category News Views 207

Shareholder Investigations: An Overview In recent months, Grabar Law Office has taken significant steps to investigate potential breaches of fiduciary duties affecting shareholders of several prominent companies. Shareholders deserve to know if their interests have been compromised by those in positions of authority, and as such, active investigations have commenced....

Continue Reading
Synaptics to Showcase Innovations at Investor Conferences

Updated Category News Views 132

Synaptics to Showcase Innovations at Investor Conferences SAN JOSE, Calif. — Synaptics Incorporated (NASDAQ: SYNA) has announced an exciting opportunity for investors, as the company is set to participate in significant upcoming investor conferences. These events aim to highlight Synaptics' commitment to innovation, particularly its pioneering work in artificial...

Continue Reading
Kite Realty Group Elevates Growth with Strong Q2 2025 Results

Updated Category News Views 150

Kite Realty Group Reports Strong Financial Performance in Q2 2025 Kite Realty Group (NYSE: KRG), a leader in managing grocery-anchored retail centers, announced impressive operating results for the second quarter of 2025. The company reported a net income attributable to common shareholders of $110.3 million, or $0.50 per diluted share, a significant turnaround from the...

Continue Reading